Protriptyline and Ethynodiol: Interaction Details

Brand names
Protriptyline
Vivactil
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Ethynodiol

We don't have a drug information page for Ethynodiol yet. Have a question about Ethynodiol? Ask a pharmacist, free →

What Happens When You Take Protriptyline With Ethynodiol

What can happen when they are taken together (rated Moderate)

Attenuation of antidepressant effectiveness; tricyclic toxicity (drowsiness, , akathisia)

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Estrogens can, in isolated cases, either enhance or diminish the pharmacologic effects of .3 In some instances the patient shows a paradoxical picture, losing the antidepressant effect while at the same time developing signs of tricyclic toxicity.1

The interaction seems to depend on the estrogen dose.2 Its clinical importance is likely greatest in patients who have already been stabilized on a tricyclic and then begin estrogen therapy.6

The Protriptyline and Ethynodiol Interaction, Explained

Protriptyline is an antidepressant, and ethynodiol is a hormone (an estrogen-type ingredient used in birth control pills). In some people, the hormone may change how the body handles the antidepressant. This can look confusing: the antidepressant may seem to work less well, while side effects such as drowsiness, dizziness from low blood pressure, or restlessness show up at the same time.

This is based on theory and isolated reports, and it seems to matter most if you were already stable on protriptyline and then start the hormone. Keep taking both as prescribed and tell your pharmacist or doctor about any changes in mood or side effects. Your care team can adjust doses and keep a closer eye on you.

Mechanism: Possible estrogen-enhanced of protriptyline (theoretical). Neither drug is a in this context. Isolated reports describe variable TCA response, including loss of antidepressant with concurrent TCA toxicity (, , akathisia).

  • Direction/magnitude: Variable; appears estrogen dose-related. No quantified data.
  • Onset: Delayed. Most relevant when estrogen is started in patients stabilized on a TCA.
  • Evidence: Theoretical, isolated cases. Severity: moderate.
  • Management: Monitor clinical response and adverse effects after estrogen initiation. If altered TCA response occurs, reduce the dose of the estrogen or the TCA; withdrawal of one agent may be required. Consider TCA levels where available.

See the 9 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Protriptyline and Ethynodiol Interact

The likely mechanism

Possible estrogen-enhanced of the tricyclic

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Protriptyline and Ethynodiol Interaction

Your care team can usually manage this by tailoring doses and monitoring you more closely, especially when the hormone is newly started.

  • Keep taking both medicines as prescribed unless told otherwise.
  • Tell your pharmacist or prescriber if your mood worsens or if you notice more drowsiness, lightheadedness, or restlessness.
  • If problems appear, the dose of either the hormone or the antidepressant may be lowered and individualized by your care team.
  • In some cases, one of the medicines may need to be stopped, but only your prescriber should decide that.

Mention it if you start or change a hormone product while on protriptyline.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Protriptyline or Ethynodiol need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

Literature Reports

7 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Estrogens may well affect response to antidepressants

    Several studies examined the qualitative effects of giving estrogen and together. In one trial, 30 depressed female prisoners were randomly allocated to 4 treatment groups.

    Ten patients were given placebo, 10 were given imipramine (150 milligrams/day) with placebo, 5 were given imipramine (150 milligrams/day) with ethinyl estradiol (50 micrograms/day), and 5 were given imipramine (150 milligrams/day) with ethinyl estradiol (25 micrograms/day). The 10 placebo patients showed no improvement during the 6-week study.

    The 10 patients receiving estrogen with imipramine showed significantly greater symptom improvement than the 10 patients receiving imipramine alone. After 2 weeks, however, the 5 patients on imipramine with high-dose estrogen had improved less than those on imipramine with low-dose estrogen.

    Drowsiness was the only side effect reported, and it occurred only in patients taking imipramine. After ethinyl estradiol was stopped, the high-dose estrogen group needed 2 weeks to reach the same level as the low-dose group.

    This was attributed to residual estrogen in the high-dose group. In another group, 5 women given imipramine 150 milligrams and ethinyl estradiol 50 micrograms daily improved less than 10 patients given imipramine alone. In addition, patients on the combination had severe side effects, including lethargy, coarse tremor, and systolic .1

  2. Report 2 · Study title

    Estrogen-imipramine interaction (letter)

    One case showed an interaction in a 32-year-old woman taking conjugated estrogens 2.5 milligrams and imipramine 100 milligrams. She developed lethargy, tremors, and signs of depersonalization.

    After 2 years of therapy, she raised her estrogen dose to 5 milligrams and then to 7.5 milligrams daily. She then experienced nausea, constant headaches, and low normal blood pressure.

    All laboratory results were normal. The side effects subsided when the estrogen was discontinued.2 Some investigators have suggested that the side effects were due to enhanced effects resulting from estrogen of microsomal enzymes.3

  3. Report 3 · Study title

    Drug interactions with clomipramine

    In one study, women received either clomipramine with oral contraceptives or clomipramine alone. At the start, 30 women were taking the combination, but 12 later dropped out.

    The 18 remaining patients on the combination were matched with 18 patients taking clomipramine alone. No significant difference was found in the patients' responses to clomipramine.

    It was suggested that side effects did not differ significantly between the groups; however, matching took place after patients had dropped out of the study. Had patients been matched before the study, different conclusions might have been reached.4

  4. Report 4 · Study title

    Influences of age, cigarette smoking and the oral contraceptive on plasma concentrations of clomipramine

    The effects of oral contraceptives on clomipramine were studied in 42 women aged 18 to 40 years. Twenty-three women took clomipramine 25 milligrams at bedtime, and 19 took clomipramine 25 milligrams at bedtime together with oral contraceptives.

    During the 4-week study, 3 patients in the control group (2 because of side effects) and 5 in the experimental group (2 because of side effects) dropped out. Venous blood samples were collected weekly to measure serum clomipramine concentrations.

    No difference in was observed between the groups. This finding may, however, be partly explained by the low clomipramine dose used.5

  5. Report 5 · Study title

    Tricyclic-induced akathisia in patients taking conjugated estrogens

    Akathisia was reported in 3 patients who were receiving conjugated estrogens and at the same time. A 24-year-old patient taking clomipramine 120 milligrams/day for anorexia nervosa and conjugated estrogens 1.25 milligrams/day for amenorrhea developed restless legs and a constant urge to keep moving.

    Estrogen was stopped and benztropine 2 milligrams was given, with marked reduction and resolution within 48 hours. A 55-year-old patient on conjugated estrogens 1.25 milligrams/day who was prescribed amitriptyline 50 milligrams/day for depression developed akathisia and disorientation.

    Within hours of amitriptyline, the patient was confused, restless, and had an inner urge to keep moving. Symptoms disappeared once amitriptyline was stopped.

    A positive rechallenge with doxepin 100 milligrams at one week was reported, with resolution after doxepin was discontinued. A third case of akathisia occurred in a 35-year-old patient given conjugated estrogens 1.25 milligrams/day and amitriptyline 50 milligrams/day. Akathisia appeared within a few hours of the first amitriptyline dose and resolved within 48 hours after the antidepressant was discontinued.6

  6. Report 6 · Study title

    Imipramine disposition in users of oral contraceptive steroids

    In women given low-dose oral contraceptives (50 micrograms or less of ethinyl estradiol), the absolute of imipramine rose from 27% to 44% (p less than 0.05), as shown by an increase in the .7

  7. Report 7 · Study title

    Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing

    Estrogens may inhibit the oxidation of (TCAs) through effects on microsomal enzymes.8 Many TCAs are by oxidation and conjugation pathways.

    Inhibited oxidation of TCAs could lead to accumulation and toxicity because of reduced . Estrogens are also suspected of having other central nervous system effects that produce an antidepressant action.9

Protriptyline and Ethynodiol: Common Questions

How serious is the Protriptyline and Ethynodiol interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How is the Protriptyline and Ethynodiol interaction managed?

Your care team can usually manage this by tailoring doses and monitoring you more closely, especially when the hormone is newly started. Keep taking both medicines as prescribed unless told otherwise. Tell your pharmacist or prescriber if your mood worsens or if you notice more drowsiness, lightheadedness, or restlessness. If problems appear, the dose of either the hormone or the antidepressant ma… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Protriptyline and Ethynodiol Interaction

Ask in your own words about taking Protriptyline and Ethynodiol together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (9)

  1. Prange AJ Jr: Estrogens may well affect response to antidepressants. JAMA 1972; 219:143-144.
  2. Khurana RC: Estrogen-imipramine interaction (letter). JAMA 1972; 222:702-703. PubMed
  3. Somani SM & Khurana RC: Mechanism of estrogen-imipramine interaction (letter). JAMA 1973; 223:560. DOI
  4. Beaumont G: Drug interactions with clomipramine. J Int Med Res 1973; 1:480-484.
  5. Luscombe DK & John V: Influences of age, cigarette smoking and the oral contraceptive on plasma concentrations of clomipramine. Postgrad Med J 1980; 56(suppl 1):99-102.
  6. Krishnan KR, France RD, & Ellinwood EH: Tricyclic-induced akathisia in patients taking conjugated estrogens. Am J Psychiatry 1984; 141:696-697. PubMed
  7. Abernethy DR, Greenblatt DJ, & Shader RI: Imipramine disposition in users of oral contraceptive steroids. Clin Pharmacol Ther 1984; 35:792-797. DOI
  8. John VA, Luscombe DK, & Kemp H: Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing. J Int Med Res 1980; 8(suppl 3):88-95.
  9. Oppenheim G: Estrogens in the treatment of depression: neuropharmacological mechanisms. Biol Psychiatry 1983; 18:721-725.
Was this write-up helpful?

Other Serious Interactions of Protriptyline and Ethynodiol

Also serious with Protriptyline

Also serious with Ethynodiol

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Protriptyline

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring. This interaction.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks. This interaction.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.